Vol.

No.

November 13, 2020Nov 13, 2020

DOWNLOAD THE PDF

Cover Story

Joe Biden has an unparalleled grasp of the science and politics of cancer

By Matthew Bin Han Ong

For the first time in U.S. history, the White House will soon be occupied by a president who has demonstrated a deep understanding of cancer research.

Free Guest Editorial

A Biden-Harris administration will help sustain our momentum in the fight against cancer

By Antoni Ribas

Free Obituary

David A. Ahlquist, pioneer of cancer screening, dies at 69

Clinical Trials & Tribulations

#BCSM: Breast cancer social media hashtag gives voice to a community

By Deanna J. Attai and Matthew S. Katz

In Brief

Abraham Chachoua named director of Perlmutter Cancer Center's Lung Cancer Center

CWRU and UH Researchers receive $5 million from NCI to investigate relationships between HIV and lung cancer in East Africa

John Turchi receives $2.9 million from NCI to improve effectiveness of lung cancer radiation therapy

SWOG and The Hope Foundation award two grants designed to give military veterans better access to cancer clinical trials

The US Oncology Network enrolls 100,000th patient in the Oncology Care Model

Clinical Roundup

Keytruda + Lenvima meet PFS primary endpoint in advanced RCC

KEYNOTE-695 study: Tavo + Keytruda demonstrate 30% ORR in anti-PD-1 checkpoint refractory metastatic melanoma

State-level lung cancer screening rates are not aligned with lung cancer burden in the U.S.

Diagnostic imaging may increase risk of testicular cancer

JNCCN study evaluates cost-effectiveness of olaparib for metastatic pancreatic cancer

Research detects hormone-upregulated lncRNA within the lymphocyte-specific protein tyrosine kinase discovered in prostate cancer

Drugs & Targets

FDA approves liquid biopsy NGS companion diagnostic test for multiple cancers and biomarkers

FDA issues guidance to enhance diversity in clinical trials, encourage inclusivity in medical product development

European Commission approves Opdivo + Yervoy with two cycles of chemotherapy for first-line treatment of metastatic NSCLC

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues